Category: Adamas Parkinson’s drug gains FDA approval

Adamas Parkinson’s drug gains FDA approval

  1. Adamas Parkinson’s drug gains FDA approval  BioPharma Dive
  2. ADMS Soars On FDA Nod, EARS Gets An Earful, Thumbs Up For BIIB’s Humira Biosim  Nasdaq
  3. Adamas Pharmaceuticals (ADMS) PT Raised to $33 at JMP Securities Following GOCOVRI Approval and Strong …  StreetInsider.com
  4. Full coverage

from Business – Google News http://www.biopharmadive.com/news/adamas-parkinsons-drug-gains-fda-approval/503514/

Advertisements